AffiAB® 488 Conjugated Anti-BRG1 Antibody [SN20-03]
The SWI-SNF complex is involved in the activation of transcription via the remodeling of nucleosome structure in an ATP-dependent manner. Brm (also designated SNF2α) and Brg-1 (also designated SNF2β) are the ATPase subunits of the mammalian SWI-SNF complex. Brm, Brg-1, Ini1 (integrase interactor 1, also designated SNF5) , BAF155 (also designated SRG3) and BAF170 are thought to comprise the functional core of the SWI-SNF complex. Addition of Ini1, BAF155 and BAF170 to Brg-1 appears to increase remodeling activity. Other complex subunits are thought to play regulatory roles. hSNF2L and hSNF2H both appear to be homologs of Drosophila ISWI, a Brm related ATPase that is present in chromatin remodeling complexes other than SWI/SNF, including the NURF (nucleosome remodeling factor) .
Antibody type
Recombinant Rabbit monoclonal Antibody
Uniprot ID
SwissProt: P51532 Human; SwissProt: Q3TKT4 Mouse; SwissProt: Q8K1P7 Rat
Recombinant
YES
Conjugation
iFluor™ 488
Host
Rabbit
Isotype
IgG
Clone
SN20-03
KO/KD
N/A
Species reactivity
Human, Mouse, Rat
Tested applications
IF-Tissue
Predicted species reactivity
N/A
Immunogen
Synthetic peptide within human BRG1 aa 240-280.
Storage
Store at +4°C after thawing. Aliquot store at -20°C. Avoid repeated freeze / thaw cycles.
Form
Liquid
Storage buffer
Preservative: 0.02% Sodium azide Constituents: 30% Glycerol, 1% BSA, 68.98% PBS.
Concentration
1 mg/mL.
Purity
Protein A affinity purified.
Signal pathway
N/A
Recommended dilutions
IF-Tissue: 1:200
Molecular Weight
Predicted band size: 185 kDa
Subcellular location
Nucleus.
Positive control
Rat brain tissue.